Articles published by Agilent Technologies Inc.
Agilent to Present at Evercore ISI Virtual Healthcare Conference
November 23, 2021
Via Business Wire
Tickers
A
Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results
November 22, 2021
Via Business Wire
Tickers
A
Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
November 01, 2021
Via Business Wire
Tickers
A
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
October 28, 2021
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement
September 02, 2021
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Agilent to Present at Wells Fargo Virtual Healthcare Conference
September 01, 2021
Via Business Wire
Tickers
A
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Esophageal Cancer
August 23, 2021
Via Business Wire
Tickers
A
Researchers Develop COVID-19 Severity Screening Method Based on the Agilent Cary 630 FTIR Spectrometer
August 19, 2021
Via Business Wire
Tickers
A
Agilent Reports Third-Quarter Fiscal Year 2021 Financial Results
August 17, 2021
Via Business Wire
Tickers
A
Agilent Earns 2021 Great Place to Work Certification in the U.S.
August 04, 2021
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC)
July 20, 2021
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Via Business Wire
Tickers
A
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.